Source: Health Canada shortage reports · Updated Sep 1, 2026
A shortage of Gadodiamide is anticipated but not yet confirmed. 1 product(s) have anticipated-shortage reports on file with Health Canada.
A contrast agent used to improve the clarity of MRI scans.
Products affected
0 / 1
Reports on file
16
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Anticipated
OMNISCAN
287MG · SOLUTION · GE HEALTHCARE CANADA INC
DIN 02172771 · Reason for shortage: Delay in manufacturing
Resolved
OMNISCAN
287MG · SOLUTION · GE HEALTHCARE CANADA INC
DIN 02172771 · ended Jan 2, 2025 · Demand increase for the drug.
Resolved
OMNISCAN
287MG · SOLUTION · GE HEALTHCARE CANADA INC
DIN 02172771 · ended Dec 5, 2024 · Demand increase for the drug.
Resolved
OMNISCAN
287MG · SOLUTION · GE HEALTHCARE CANADA INC
DIN 02172771 · ended Sep 27, 2024 · Delay in shipping of the drug.
Discontinued
OMNISCAN
287MG · SOLUTION · GE HEALTHCARE CANADA INC
DIN 02172771
Avoided
OMNISCAN
287MG · SOLUTION · GE HEALTHCARE CANADA INC
DIN 02172771 · ended May 13, 2022 · No longer anticipate drug shortage
Avoided
OMNISCAN
287MG · SOLUTION · GE HEALTHCARE CANADA INC
DIN 02172771 · ended May 13, 2022 · No shortage anticipated
Resolved
OMNISCAN
287MG · SOLUTION · GE HEALTHCARE CANADA INC
DIN 02172771 · ended Feb 7, 2022 · Delay in shipping of the drug.
Resolved
OMNISCAN
287MG · SOLUTION · GE HEALTHCARE CANADA INC
DIN 02172771 · ended Oct 18, 2021 · Package insert delay
Resolved
OMNISCAN
287MG · SOLUTION · GE HEALTHCARE CANADA INC
DIN 02172771 · ended Oct 18, 2021 · Delay in shipping of the drug.
Resolved
OMNISCAN
287MG · SOLUTION · GE HEALTHCARE CANADA INC
DIN 02172771 · ended May 28, 2021 · Delay in shipping of the drug.
Resolved
OMNISCAN
287MG · SOLUTION · GE HEALTHCARE CANADA INC
DIN 02172771 · ended Apr 30, 2021 · Delay in shipping of the drug.
Showing 12 of 16 reports. All reports are on file with Health Canada.
What's happening
A manufacturer has told Health Canada it expects supply of Gadodiamide to fall short of demand. Anticipated shortages sometimes resolve without patients noticing; this page updates as soon as the status changes.
Gadodiamide is classified under “MAGNETIC RESONANCE IMAGING CONTRAST MEDIA” (ATC V08CA).
Recent changes
Sep 1, 2026
New report filed
Common questions
What is Gadodiamide used for?
A contrast agent used to improve the clarity of MRI scans.
When will Gadodiamide be back in stock in Canada?
Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.
Why is Gadodiamide in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.